Armitage James O has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 40565 shares of Cardiff Oncology, Inc. ($CRDF) on June 26, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 26, 2025 | Cardiff Oncology, Inc. | $CRDF | Armitage James O | Director | A | Stock Options | 40565 | $0.00 | 187,539.0000 | 66,524,294 | 27.60% | 0.06% |
| June 27, 2024 | Cardiff Oncology, Inc. | $CRDF | Armitage James O | Director | A | Stock Options | 29700 | $0.00 | 146,974.0000 | 0 | 25.33% | 0.00% |
| June 15, 2023 | Cardiff Oncology, Inc. | $CRDF | Armitage James O | Director | A | Stock Options | 27700 | $0.00 | 117,274.0000 | 0 | 30.92% | 0.00% |